Advisor Group Holdings, Inc. Enveric Biosciences, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$8.8 - $16.2 $35,200 - $64,800	-4,000 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$12.5 - $52.0 $1,875 - $7,800	-150 Reduced 3.61%	4,000 $1,000
Q3 2021 Nov 05, 2021	BUY	$80.5 - $175.0 $92,575 - $201,250	1,150 Added 38.33%	4,150 $9,000
Q2 2021 Aug 02, 2021	BUY	$95.0 - $156.5 $180,500 - $297,350	1,900 Added 172.73%	3,000 $7,000
Q1 2021 May 13, 2021	BUY	$131.5 - $245.0 $13,150 - $24,500	100 Added 10.0%	1,100 $3,000
Q4 2020 Feb 10, 2021	BUY	$74.0 - $740.0 $74,000 - $740,000	1,000 New	1,000 $4,000

Ticker ENVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,078,270
Market Cap $1.04M
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.